Paul Morrill

556 total citations
11 papers, 418 citations indexed

About

Paul Morrill is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cellular and Molecular Neuroscience. According to data from OpenAlex, Paul Morrill has authored 11 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Paul Morrill's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Nicotinic Acetylcholine Receptors Study (3 papers) and Advanced Biosensing Techniques and Applications (2 papers). Paul Morrill is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Nicotinic Acetylcholine Receptors Study (3 papers) and Advanced Biosensing Techniques and Applications (2 papers). Paul Morrill collaborates with scholars based in United Kingdom, United States and Denmark. Paul Morrill's co-authors include Christopher R. Lowe, James W. Smithy, Maria Toki, David L. Rimm, Jamaal Rehman, Delphine Cougot, Patricia Gaule, Kenny Sproule, Susan A. Greenfield and Paul P. Lau and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Biosensors and Bioelectronics and Neuropharmacology.

In The Last Decade

Paul Morrill

11 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Morrill United Kingdom 11 177 155 92 61 53 11 418
Simon J. Henderson United Kingdom 8 240 1.4× 87 0.6× 195 2.1× 20 0.3× 27 0.5× 13 545
Michael Z. Wang United States 14 338 1.9× 75 0.5× 21 0.2× 32 0.5× 28 0.5× 21 667
John A. Cieslak United States 9 214 1.2× 59 0.4× 29 0.3× 39 0.6× 28 0.5× 16 472
Raphael Trenker Australia 11 267 1.5× 116 0.7× 86 0.9× 27 0.4× 16 0.3× 16 428
Stefanie Sommer Germany 13 477 2.7× 139 0.9× 16 0.2× 60 1.0× 32 0.6× 21 685
Pavlo Holenya Germany 12 183 1.0× 123 0.8× 23 0.3× 26 0.4× 13 0.2× 20 475
Steven M. Moss United States 15 357 2.0× 48 0.3× 23 0.3× 26 0.4× 21 0.4× 26 602
Julie Sanchez Australia 11 231 1.3× 181 1.2× 44 0.5× 23 0.4× 12 0.2× 19 498
Mostafa Erfani Iran 13 125 0.7× 107 0.7× 239 2.6× 74 1.2× 88 1.7× 75 525
Christopher E. Whitehead United States 10 291 1.6× 112 0.7× 27 0.3× 37 0.6× 18 0.3× 25 461

Countries citing papers authored by Paul Morrill

Since Specialization
Citations

This map shows the geographic impact of Paul Morrill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Morrill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Morrill more than expected).

Fields of papers citing papers by Paul Morrill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Morrill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Morrill. The network helps show where Paul Morrill may publish in the future.

Co-authorship network of co-authors of Paul Morrill

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Morrill. A scholar is included among the top collaborators of Paul Morrill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Morrill. Paul Morrill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Pepper, Chris, et al.. (2017). Tumor cell migration is inhibited by a novel therapeutic strategy antagonizing the alpha-7 receptor. Oncotarget. 8(7). 11414–11424. 16 indexed citations
4.
Gaule, Patricia, James W. Smithy, Maria Toki, et al.. (2016). A Quantitative Comparison of Antibodies to Programmed Cell Death 1 Ligand 1. JAMA Oncology. 3(2). 256–256. 148 indexed citations
5.
Morrill, Paul, Roger B. Millington, & Christopher R. Lowe. (2003). Imaging surface plasmon resonance system for screening affinity ligands. Journal of Chromatography B. 793(2). 229–251. 25 indexed citations
6.
Morrill, Paul, et al.. (2002). Rational combinatorial chemistry-based selection, synthesis and evaluation of an affinity adsorbent for recombinant human clotting factor VII. Journal of Chromatography B. 774(1). 1–15. 26 indexed citations
7.
Sproule, Kenny, Paul Morrill, James C. Pearson, et al.. (2000). New strategy for the design of ligands for the purification of pharmaceutical proteins by affinity chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 740(1). 17–33. 63 indexed citations
8.
Morrill, Paul, et al.. (1999). An optical biosensor for monitoring recombinant proteins in process media. Biosensors and Bioelectronics. 14(5). 481–493. 21 indexed citations
9.
McCabe, R E, et al.. (1991). In vitro model of attachment of Giardia intestinalis trophozoites to IEC-6 cells, an intestinal cell line. Antimicrobial Agents and Chemotherapy. 35(1). 29–35. 30 indexed citations
10.
Lau, Paul P., Michael A. Dubick, Gloria S.M. Yu, Paul Morrill, & Michael C. Geokas. (1990). Dynamic changes of pancreatic structure and function in rats treated chronically with nicotine. Toxicology and Applied Pharmacology. 104(3). 457–465. 21 indexed citations
11.
Lau, Paul P., et al.. (1988). Altered exocrine pancreatic function in rats treated with nicotine. Toxicology and Applied Pharmacology. 96(1). 132–139. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026